Benjamin Haynor
Stock Analyst at Lake Street
(1.12)
# 3,656
Out of 4,947 analysts
10
Total ratings
33.33%
Success rate
-2.55%
Average return
Main Sectors:
Stocks Rated by Benjamin Haynor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PROF Profound Medical | Maintains: Buy | $17 → $11 | $4.35 | +152.87% | 1 | Apr 23, 2025 | |
| VSAT Viasat | Maintains: Buy | $31 → $19 | $27.27 | -30.33% | 5 | Sep 20, 2024 | |
| CGNT Cognyte Software | Downgrades: Hold | n/a | $8.77 | - | 2 | Mar 13, 2018 | |
| DRIO DarioHealth | Initiates: Buy | $70 | $0.45 | +15,514.54% | 1 | Aug 29, 2017 | |
| SRDX Surmodics | Initiates: Buy | $44 | $38.19 | +13.90% | 1 | Jun 27, 2017 |
Profound Medical
Apr 23, 2025
Maintains: Buy
Price Target: $17 → $11
Current: $4.35
Upside: +152.87%
Viasat
Sep 20, 2024
Maintains: Buy
Price Target: $31 → $19
Current: $27.27
Upside: -30.33%
Cognyte Software
Mar 13, 2018
Downgrades: Hold
Price Target: n/a
Current: $8.77
Upside: -
DarioHealth
Aug 29, 2017
Initiates: Buy
Price Target: $70
Current: $0.45
Upside: +15,514.54%
Surmodics
Jun 27, 2017
Initiates: Buy
Price Target: $44
Current: $38.19
Upside: +13.90%